Protagonist Therapeutics (PTGX) Competitor Comparison
We are evaluating the key criteria listed to compare Protagonist Therapeutics (PTGX) against its competitors in the Biotechnology industry.
Market Capitalization
92 / 368Gross Profits
80 / 278Total Revenue
297 / 300EBITDA
248 / 337Free Cashflow
249 / 352Quick Ratio
63 / 357Earnings per Share
10 / 359Dividend yield
0 / 6Total Cash
103 / 358Performance 3 years
72 / 368Performance 5 years
13 / 368Performance 10 years
30 / 368Linearity 3 years
61 / 368Linearity 5 years
341 / 368Linearity 10 years
345 / 367Total Rank
347 / 368Dividend Rank
246 / 368Valuation Rank
173 / 368Piotroski Rank
251 / 368Muliplier Rank
183 / 368Market Capitalization - PTGX ranking 92 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.